Herbal granules aim to ease Post-Meal stomach troubles

NCT ID NCT06696261

Recruiting now Symptom relief Sponsor: Tasly Pharmaceutical Group Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Phase 3 trial tests whether Lianxiaxiaopi Granules, a traditional Chinese herbal medicine, can relieve symptoms of postprandial distress syndrome (stomach discomfort, fullness, or early fullness after meals). 342 adults aged 18-65 will take the granules or a placebo three times daily for 8 weeks. The study measures how many weeks symptoms improve by at least half compared to baseline.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Lianxiaxiaopi Granules (herbal granules)
What this could lead to: If successful, this could provide a new herbal treatment option for people with postprandial distress syndrome, reducing discomfort after meals.
What could go wrong: This is a Phase 3 trial, but the intervention is based on Traditional Chinese Medicine concepts (cold/heat imbalance) which may not be accepted by all. The placebo response in digestive disorders can be high, so the real benefit may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dyspepsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POSTPRANDIAL DISTRESS SYNDROME

Contacts and locations

Locations

Baoding No. 1 Hospital of Traditional Chinese Medicine
NOT_YET_RECRUITING

Baoding, Heibei, China
Gansu Provincial Hospital of Traditional Chinese Medicine
NOT_YET_RECRUITING

Lanzhou, Gansu, China
General Hospital of the Northern Theater of the Chinese People's Liberation Army
NOT_YET_RECRUITING

Shenyang, Liaoning, China
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
NOT_YET_RECRUITING

Beijing, Beijing Municipality, China
Hebei Provincial Hospital of Traditional Chinese Medicine
NOT_YET_RECRUITING

Shijiazhuang, Hebei, China
The Affiliated Hospital of Changchun University of Traditional Chinese Medicine
NOT_YET_RECRUITING

Changchun, Jilin, China
The Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
RECRUITING

Chengdu, Sichuan, China
The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
NOT_YET_RECRUITING

Shenyang, Liaoning, China
The Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine
NOT_YET_RECRUITING

Xianyang, Shanxi, China
The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
NOT_YET_RECRUITING

Guiyang, Guizhou, China
The First Affiliated Hospital of Kunming Medical University
NOT_YET_RECRUITING

Kunming, Yunnan, China
The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
NOT_YET_RECRUITING

Tianjin, Tianjin Municipality, China
The First People's Hospital of Luoyang City
RECRUITING

Luoyang, Henan, China
The Second Affiliated Hospital of Xingtai Medical College
NOT_YET_RECRUITING

Xingtai, Hebei, China
Wenzhou Hospital of Traditional Chinese Medicine
NOT_YET_RECRUITING

Wenzhou, Zhejiang, China
West China Hospital Sichuan University
NOT_YET_RECRUITING

Chengdu, Sichuan, China
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine
NOT_YET_RECRUITING

Shanghai, Shanghai Municipality, China
Zhejiang Provincial Hospital of Traditional Chinese Medicine
NOT_YET_RECRUITING

Hangzhou, Zhejiang, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.